Profarma Distribuidora de Produtos Farmacêuticos S.A.

São Paulo Stock Exchange PFRM3.SA

Profarma Distribuidora de Produtos Farmacêuticos S.A. Free Cash Flow Yield on January 14, 2025: 42.01%

Profarma Distribuidora de Produtos Farmacêuticos S.A. Free Cash Flow Yield is 42.01% on January 14, 2025, a 2.12% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Profarma Distribuidora de Produtos Farmacêuticos S.A. 52-week high Free Cash Flow Yield is 45.98% on February 14, 2024, which is 9.45% above the current Free Cash Flow Yield.
  • Profarma Distribuidora de Produtos Farmacêuticos S.A. 52-week low Free Cash Flow Yield is 30.53% on November 06, 2024, which is -27.32% below the current Free Cash Flow Yield.
  • Profarma Distribuidora de Produtos Farmacêuticos S.A. average Free Cash Flow Yield for the last 52 weeks is 39.08%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
São Paulo Stock Exchange: PFRM3.SA

Profarma Distribuidora de Produtos Farmacêuticos S.A.

CEO Mr. Sammy Birmarcker
IPO Date Oct. 26, 2006
Location Brazil
Headquarters Avenida Ayrton Senna 2.150
Employees 7,077
Sector Health Care
Industries
Description

Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company operates through Distribution, and Retail segments. It provides branded medicines, generic drugs, and over-the-counter (OTC) medicines; personal hygiene, beauty, and cosmetic products, such as shampoos, conditioners, treatment creams and hair dyes, diapers and children's products, soaps , deodorants, oral care products, sunscreens, male products, cosmetics, makeup and skin products, and others; and hospital products, including injectable and infusion drugs for oncology, endocrinology, rheumatology, infectology, hematology, and other specialties. The company also offers vaccines for influenza, HPV, meningitis, hepatitis, chickenpox, dengue, and other diseases; special medicines intended for the treatment of rare and complex diseases; exclusive hygiene and beauty products, vitamins, and workshops products under the Nº21, GOnutri, and Bem Básico brands; and convenience products, including food products, pressure gauges, scales, and related products. In addition, it provides complementary services, such as promotional and logistical support, implementation of promotional campaigns, product recall, development of customized projects to offer laboratories solutions, and management of clinical procedures. As of December 31, 2019, the company operated eleven distribution centers located in the states of Alagoas, Bahia, Espírito Santo, Goiás, Minas Gerais, Paraíba, Paraná, Pernambuco, Rio Grande do Sul, Rio de Janeiro, and São Paulo, as well as approximately 196 stores in the states of Rio de Janeiro, Goiás, Tocantins, Mato Grosso, and Distrito Federal under the Drogarias Tamoio, Drogasmil, Farmalife, and Rede Rosário brands. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil.

Similar companies

TCSA3.SA

Tecnisa S.A.

USD 0.23

-0.87%

POSI3.SA

Positivo Tecnologia S.A.

USD 0.82

-0.45%

JHSF3.SA

JHSF Participações S.A.

USD 0.61

1.93%

ODPV3.SA

Odontoprev S.A.

USD 1.77

2.65%

StockViz Staff

January 15, 2025

Any question? Send us an email